Filing Details

Accession Number:
0001209191-11-029466
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-18 17:54:33
Reporting Period:
2011-05-16
Filing Date:
2011-05-18
Accepted Time:
2011-05-18 17:54:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051411 T Erle Mast C/O Somaxon Pharmaceuticals, Inc.
3570 Carmel Mountain Road, Suite 100
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-05-16 5,000 $2.65 36,630 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.